United States Endometriosis Treatment Market Report 2017

August 2017 | 104 pages | ID: U87BC12C415EN
QYResearch

Abstracts

In this report, the United States Endometriosis Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Endometriosis Treatment in these regions, from 2012 to 2022 (forecast).

United States Endometriosis Treatment market competition by top manufacturers/players, with Endometriosis Treatment sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Eli Lilly
• AstraZeneca
• Bayer AG
• Astellas Pharma
• Abbvie
• Meditrina Pharmaceuticals
• Pfizer
• Neurocrine Biosciences
• Takeda Pharmaceutical

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Gonadotropins Releasing Hormone Agonists
• Progestin
• Non-Steroidal Anti-Inflammatory Drugs
• Oral Contraceptive Pills

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Endometriosis Treatment for each application, including

• Hospital Pharmacies
• Drug Stores
• Mail Order Pharmacies
• Retail Pharmacies
• E-Commerce
• Others

Contents

United States Endometriosis Treatment Market Report 2017

1 ENDOMETRIOSIS TREATMENT OVERVIEW

1.1 Product Overview and Scope of Endometriosis Treatment
1.2 Classification of Endometriosis Treatment by Product Category
  1.2.1 United States Endometriosis Treatment Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Endometriosis Treatment Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Gonadotropins Releasing Hormone Agonists
  1.2.4 Progestin
  1.2.5 Non-Steroidal Anti-Inflammatory Drugs
  1.2.6 Oral Contraceptive Pills
1.3 United States Endometriosis Treatment Market by Application/End Users
  1.3.1 United States Endometriosis Treatment Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital Pharmacies
  1.3.3 Drug Stores
  1.3.4 Mail Order Pharmacies
  1.3.5 Retail Pharmacies
  1.3.6 E-Commerce
  1.3.7 Others
1.4 United States Endometriosis Treatment Market by Region
  1.4.1 United States Endometriosis Treatment Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Endometriosis Treatment Status and Prospect (2012-2022)
  1.4.3 Southwest Endometriosis Treatment Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Endometriosis Treatment Status and Prospect (2012-2022)
  1.4.5 New England Endometriosis Treatment Status and Prospect (2012-2022)
  1.4.6 The South Endometriosis Treatment Status and Prospect (2012-2022)
  1.4.7 The Midwest Endometriosis Treatment Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Endometriosis Treatment (2012-2022)
  1.5.1 United States Endometriosis Treatment Sales and Growth Rate (2012-2022)
  1.5.2 United States Endometriosis Treatment Revenue and Growth Rate (2012-2022)

2 UNITED STATES ENDOMETRIOSIS TREATMENT MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Endometriosis Treatment Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Endometriosis Treatment Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Endometriosis Treatment Average Price by Players/Suppliers (2012-2017)
2.4 United States Endometriosis Treatment Market Competitive Situation and Trends
  2.4.1 United States Endometriosis Treatment Market Concentration Rate
  2.4.2 United States Endometriosis Treatment Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Endometriosis Treatment Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ENDOMETRIOSIS TREATMENT SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Endometriosis Treatment Sales and Market Share by Region (2012-2017)
3.2 United States Endometriosis Treatment Revenue and Market Share by Region (2012-2017)
3.3 United States Endometriosis Treatment Price by Region (2012-2017)

4 UNITED STATES ENDOMETRIOSIS TREATMENT SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Endometriosis Treatment Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Endometriosis Treatment Revenue and Market Share by Type (2012-2017)
4.3 United States Endometriosis Treatment Price by Type (2012-2017)
4.4 United States Endometriosis Treatment Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ENDOMETRIOSIS TREATMENT SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Endometriosis Treatment Sales and Market Share by Application (2012-2017)
5.2 United States Endometriosis Treatment Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ENDOMETRIOSIS TREATMENT PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Eli Lilly
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Endometriosis Treatment Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Eli Lilly Endometriosis Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 AstraZeneca
  6.2.2 Endometriosis Treatment Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 AstraZeneca Endometriosis Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Bayer AG
  6.3.2 Endometriosis Treatment Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Bayer AG Endometriosis Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Astellas Pharma
  6.4.2 Endometriosis Treatment Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Astellas Pharma Endometriosis Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Abbvie
  6.5.2 Endometriosis Treatment Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Abbvie Endometriosis Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Meditrina Pharmaceuticals
  6.6.2 Endometriosis Treatment Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Meditrina Pharmaceuticals Endometriosis Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Pfizer
  6.7.2 Endometriosis Treatment Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Pfizer Endometriosis Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Neurocrine Biosciences
  6.8.2 Endometriosis Treatment Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Neurocrine Biosciences Endometriosis Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Takeda Pharmaceutical
  6.9.2 Endometriosis Treatment Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Takeda Pharmaceutical Endometriosis Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 ENDOMETRIOSIS TREATMENT MANUFACTURING COST ANALYSIS

7.1 Endometriosis Treatment Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Endometriosis Treatment

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Endometriosis Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Endometriosis Treatment Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Endometriosis Treatment Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Endometriosis Treatment Sales Volume Forecast by Type (2017-2022)
11.3 United States Endometriosis Treatment Sales Volume Forecast by Application (2017-2022)
11.4 United States Endometriosis Treatment Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Endometriosis Treatment
Figure United States Endometriosis Treatment Market Size (K Units) by Type (2012-2022)
Figure United States Endometriosis Treatment Sales Volume Market Share by Type (Product Category) in 2016
Figure Gonadotropins Releasing Hormone Agonists Product Picture
Figure Progestin Product Picture
Figure Non-Steroidal Anti-Inflammatory Drugs Product Picture
Figure Oral Contraceptive Pills Product Picture
Figure United States Endometriosis Treatment Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Endometriosis Treatment by Application in 2016
Figure Hospital Pharmacies Examples
Figure Drug Stores Examples
Figure Mail Order Pharmacies Examples
Figure Retail Pharmacies Examples
Figure E-Commerce Examples
Figure Others Examples
Figure United States Endometriosis Treatment Market Size (Million USD) by Region (2012-2022)
Figure The West Endometriosis Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Endometriosis Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Endometriosis Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Endometriosis Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Endometriosis Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Endometriosis Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Endometriosis Treatment Sales (K Units) and Growth Rate (2012-2022)
Figure United States Endometriosis Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Endometriosis Treatment Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Endometriosis Treatment Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Endometriosis Treatment Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Endometriosis Treatment Sales Share by Players/Suppliers
Figure 2017 United States Endometriosis Treatment Sales Share by Players/Suppliers
Figure United States Endometriosis Treatment Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Endometriosis Treatment Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Endometriosis Treatment Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Endometriosis Treatment Revenue Share by Players/Suppliers
Figure 2017 United States Endometriosis Treatment Revenue Share by Players/Suppliers
Table United States Market Endometriosis Treatment Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Endometriosis Treatment Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Endometriosis Treatment Market Share of Top 3 Players/Suppliers
Figure United States Endometriosis Treatment Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Endometriosis Treatment Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Endometriosis Treatment Product Category
Table United States Endometriosis Treatment Sales (K Units) by Region (2012-2017)
Table United States Endometriosis Treatment Sales Share by Region (2012-2017)
Figure United States Endometriosis Treatment Sales Share by Region (2012-2017)
Figure United States Endometriosis Treatment Sales Market Share by Region in 2016
Table United States Endometriosis Treatment Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Endometriosis Treatment Revenue Share by Region (2012-2017)
Figure United States Endometriosis Treatment Revenue Market Share by Region (2012-2017)
Figure United States Endometriosis Treatment Revenue Market Share by Region in 2016
Table United States Endometriosis Treatment Price (USD/Unit) by Region (2012-2017)
Table United States Endometriosis Treatment Sales (K Units) by Type (2012-2017)
Table United States Endometriosis Treatment Sales Share by Type (2012-2017)
Figure United States Endometriosis Treatment Sales Share by Type (2012-2017)
Figure United States Endometriosis Treatment Sales Market Share by Type in 2016
Table United States Endometriosis Treatment Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Endometriosis Treatment Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Endometriosis Treatment by Type (2012-2017)
Figure Revenue Market Share of Endometriosis Treatment by Type in 2016
Table United States Endometriosis Treatment Price (USD/Unit) by Types (2012-2017)
Figure United States Endometriosis Treatment Sales Growth Rate by Type (2012-2017)
Table United States Endometriosis Treatment Sales (K Units) by Application (2012-2017)
Table United States Endometriosis Treatment Sales Market Share by Application (2012-2017)
Figure United States Endometriosis Treatment Sales Market Share by Application (2012-2017)
Figure United States Endometriosis Treatment Sales Market Share by Application in 2016
Table United States Endometriosis Treatment Sales Growth Rate by Application (2012-2017)
Figure United States Endometriosis Treatment Sales Growth Rate by Application (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Endometriosis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly Endometriosis Treatment Sales Growth Rate (2012-2017)
Figure Eli Lilly Endometriosis Treatment Sales Market Share in United States (2012-2017)
Figure Eli Lilly Endometriosis Treatment Revenue Market Share in United States (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Endometriosis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Endometriosis Treatment Sales Growth Rate (2012-2017)
Figure AstraZeneca Endometriosis Treatment Sales Market Share in United States (2012-2017)
Figure AstraZeneca Endometriosis Treatment Revenue Market Share in United States (2012-2017)
Table Bayer AG Basic Information List
Table Bayer AG Endometriosis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer AG Endometriosis Treatment Sales Growth Rate (2012-2017)
Figure Bayer AG Endometriosis Treatment Sales Market Share in United States (2012-2017)
Figure Bayer AG Endometriosis Treatment Revenue Market Share in United States (2012-2017)
Table Astellas Pharma Basic Information List
Table Astellas Pharma Endometriosis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Astellas Pharma Endometriosis Treatment Sales Growth Rate (2012-2017)
Figure Astellas Pharma Endometriosis Treatment Sales Market Share in United States (2012-2017)
Figure Astellas Pharma Endometriosis Treatment Revenue Market Share in United States (2012-2017)
Table Abbvie Basic Information List
Table Abbvie Endometriosis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbvie Endometriosis Treatment Sales Growth Rate (2012-2017)
Figure Abbvie Endometriosis Treatment Sales Market Share in United States (2012-2017)
Figure Abbvie Endometriosis Treatment Revenue Market Share in United States (2012-2017)
Table Meditrina Pharmaceuticals Basic Information List
Table Meditrina Pharmaceuticals Endometriosis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Meditrina Pharmaceuticals Endometriosis Treatment Sales Growth Rate (2012-2017)
Figure Meditrina Pharmaceuticals Endometriosis Treatment Sales Market Share in United States (2012-2017)
Figure Meditrina Pharmaceuticals Endometriosis Treatment Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Endometriosis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Endometriosis Treatment Sales Growth Rate (2012-2017)
Figure Pfizer Endometriosis Treatment Sales Market Share in United States (2012-2017)
Figure Pfizer Endometriosis Treatment Revenue Market Share in United States (2012-2017)
Table Neurocrine Biosciences Basic Information List
Table Neurocrine Biosciences Endometriosis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Neurocrine Biosciences Endometriosis Treatment Sales Growth Rate (2012-2017)
Figure Neurocrine Biosciences Endometriosis Treatment Sales Market Share in United States (2012-2017)
Figure Neurocrine Biosciences Endometriosis Treatment Revenue Market Share in United States (2012-2017)
Table Takeda Pharmaceutical Basic Information List
Table Takeda Pharmaceutical Endometriosis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Takeda Pharmaceutical Endometriosis Treatment Sales Growth Rate (2012-2017)
Figure Takeda Pharmaceutical Endometriosis Treatment Sales Market Share in United States (2012-2017)
Figure Takeda Pharmaceutical Endometriosis Treatment Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Endometriosis Treatment
Figure Manufacturing Process Analysis of Endometriosis Treatment
Figure Endometriosis Treatment Industrial Chain Analysis
Table Raw Materials Sources of Endometriosis Treatment Major Players/Suppliers in 2016
Table Major Buyers of Endometriosis Treatment
Table Distributors/Traders List
Figure United States Endometriosis Treatment Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Endometriosis Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Endometriosis Treatment Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Endometriosis Treatment Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Endometriosis Treatment Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Endometriosis Treatment Sales Volume (K Units) Forecast by Type in 2022
Table United States Endometriosis Treatment Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Endometriosis Treatment Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Endometriosis Treatment Sales Volume (K Units) Forecast by Application in 2022
Table United States Endometriosis Treatment Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Endometriosis Treatment Sales Volume Share Forecast by Region (2017-2022)
Figure United States Endometriosis Treatment Sales Volume Share Forecast by Region (2017-2022)
Figure United States Endometriosis Treatment Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources